A registered report of error-related negativity and reward positivity as biomarkers of depression: P-Curving the evidence
Performance-monitoring event-related brain potentials (ERPs), such as the error-related negativity (ERN) and reward positivity (RewP), are advocated as biomarkers of depression symptoms and risk. However, a recent meta-analysis indicated effect size heterogeneity in the ERN and RewP literatures. Hen...
Gespeichert in:
Veröffentlicht in: | International journal of psychophysiology 2020-04, Vol.150, p.50-72 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Performance-monitoring event-related brain potentials (ERPs), such as the error-related negativity (ERN) and reward positivity (RewP), are advocated as biomarkers of depression symptoms and risk. However, a recent meta-analysis indicated effect size heterogeneity in the ERN and RewP literatures. Hence, advocating these ERPs as biomarkers of depression might be premature or possibly misguided due to the selective reporting of significant analyses on the part of researchers (e.g., p-hacking or omission of non-significant findings). The present study quantified the degree of selective reporting and the evidential value for a true relationship between depression and ERN and RewP using a p-curve analysis. We predicted that the ERN and RewP literatures would fail to show evidential value for a relationship between each ERP and depression. Contrary to expectations, both literatures showed evidential value, albeit weak. The statistical power of the included ERN studies was between 20% and 25%, and the statistical power of the RewP was around 27%. Taken together, these findings provide support for a relationship between these ERPs and depression, which strengthens claims that these ERPs represent candidate biomarkers of depression symptoms and risk. In light of the evidence for these relationships being weak, some recommendations moving forward include conducting a priori power analyses, increasing sample sizes to improve statistical power, assessing the internal consistency of ERP scores, and carefully planning statistical approaches to maximize power.
•ERN and RewP are advocated as biomarkers of depression symptoms and risk.•This might be premature due to the selective reporting of significant analyses.•Evidential value, albeit weak, was observed for depression and ERN/RewP.•Statistical power was between 20% and 27% for included studies.•A priori power analyses and increased samples sizes are need moving forward. |
---|---|
ISSN: | 0167-8760 1872-7697 |
DOI: | 10.1016/j.ijpsycho.2020.01.005 |